BACKGROUND: Actinic cheilitis (AC) is an oral potentially malignant lesion which is the counterpart of actinic keratosis of the skin and has potential to develop into squamous cell carcinoma. Regulatory T cells (Tregs) have a critical role in modulating the antitumor immune responses. The presence of regulatory T cells in potentially malignant lesions has not been described. We chose investigate the involvement of regulatory T cells in potentially malignant lesions. METHODS: The frequency, phenotype, and activity of CD4+CD25+ T cells isolated from blood and lesion of AC patients were analyzed by flow cytometry. Cytokines were quantified by ELISA. Data were compared with samples from healthy subjects. RESULTS: The frequency and suppressor activity of circulating CD4+CD25+ T cells was similar in AC patients and control subjects. However, the frequencies of IL-10-positive Tregs were higher in AC patients, and these cells inhibited interferon-gamma (IFN-c) and increased interleukin (IL)-10 productions in co-cultures. Furthermore, CD4+CD25+ T cells accumulate in AC lesions. Lesionsderived regulatory T cells suppressed lymphocyte proliferation and pro-inflammatory cytokine production. Moreover, high levels of IL-10 and transforming growth factor-b (TGF-b), and low IFN-c were detected in the potentially malignant lesions. CONCLUSION: Therefore, our data show that Tregs accumulate in AC lesions, and these cells could be suppressing immune responses in a potentially malignant microenvironment. 
Introduction
Actinic cheilitis (AC) is a potentially malignant lesion of the lip predominantly induced by chronic exposure to the ultraviolet (UV) sunlight (1) . AC lesions are characterized by epithelial and connective tissue alterations with increased immune cell infiltration that has potential to develop oral squamous cell carcinoma (OSCC) (2, 3) . However, the events leading to AC malignant transformation remain to be elucidated. Molecular markers and immunoregulatory events that could predict AC malignant potential are not well established (4) .
Regulatory T cells (Tregs), particularly those of the Foxp3 + subtype, play an important role in immune homeostasis modulating the activation, proliferation, and effector function of conventional T cells in several immunological settings (5) (6) (7) . Tregs also are involved in tumor escape because of their ability to suppress the effector immune response of lymphocytes against tumor antigens (6) (7) (8) (9) (10) (11) . Tregs limit the development of T helper type 1 (Th1) immune responses that drive CD8 + T cells and IFN-gammadependent antitumor immunity, and blockade of their activity provides effective therapy against cancer (12, 13) . Malignant environment could also convert na€ ıve peripheral CD4 + Foxp3 À into Foxp3 + Tregs after activation by T-cell receptor (TCR) in the presence of TGF-b (14) (15) (16) . Although these reports suggested a direct correlation between Tregs and the suppression of the immune response in tumor microenvironment, the presence and characteristics of Tregs in potentially malignant lesion have not been described. We hypothesize that Treg cells in a malignant environment impairs T-cells-mediated immune response, thereby leaving the development of SCC. To address this hypothesis, we investigate the presence, functional and phenotypic characteristics of Tregs in the peripheral blood (PBMC) and lesions from AC patients.
Material and methods

Subjects and study design
We used peripheral blood mononuclear cells (PBMCs) from thirteen patients with a diagnosis of actinic cheilitis (age ranged 38-86 years and mean = 65.4 AE 1.8 years old), as well as 11 age-matched healthy volunteers (age ranged 27-74 years and mean = 58.4 AE 2.2 years old). To be considered eligible for inclusion in the study, a patient had to be over the age of 18 years and to have a histological analysis showing epithelial changes restricted to the lower two-thirds of the epithelium, comprising 'mild' (grade 1) and 'moderate' (grade 2) dysplasia (17) To confirm the clinical diagnosis, incisional biopsies were performed in areas of erythema, paleness, ulceration, or atrophy, and hematoxylin and eosinstained sections were examined under a light microscope. Of the thirteen patients enrolled in the study, nine patients had a vermilionectomy indication as an therapy. Tissue control samples were obtained from esthetic or orthodontic surgical indication. All subjects signed an informed consent allowing the use of specimens (tissues and blood) for research purposes approved by Bauru School of Dentistry, University of São Paulo (Proc. #04/2006). We collected all blood samples from subjects with AC and controls at 9:00 a.m. in heparinized vacutainers (BD Biosciences, Milan, Italy) and processed them within the following 30 min.
Chemical reagents
Leukocytes obtained from blood and oral tissues were cultivated in RPMI 1640 medium (Invitrogen Life Technologies, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal calf serum (FCS, GIBCO), 100 U/ml penicillin, 100 lg/ml streptomycin, 2 mM L-glutamine, 10 mM HEPES, 0.1 mM nonessential amino acids, and 1 mM sodium pyruvate (all from Sigma-Aldrich, St. Louis, MO, USA). Phytohemagglutinin (PHA) and PE-conjugated streptavidin were purchased from Invitrogen Life Technologies. All cultures and co-cultures were performed in RPMI 1640 plus 10% fetal bovine serum (FBS), 2 mM-glutamine, 50 U/ml penicillin, and 50 lg/ml streptomycin (GIBCO BRL)-complete RPMI.
Histopathologic analysis
For histological analysis, excised tissue samples were fixed with 10% buffered formalin and processed using routine histological techniques. Tissue sections were stained with H&E and analyzed by light microscopy.
Flow cytometry
For immunostaining, PerCP, PE-and FITC-conjugated Abs against CD3 (UCHT 1), CD4 (RPA-T4), CD8 (RPA-T8), CD19 (HIB 19), CD25 (M-A251), CD45RO (UCHL 1), CD152 (BNI3.1), CD103 (Ber-ACT8), CD69 (FN50), CCR4 (1G1), Foxp3 (PCH101) (BD Biosciences, San Diego, CA, USA), and respective mouse and rat isotype controls were used (BD). PE-conjugated mice monoclonal antibody (mAb), antihuman GITR (110416), and biotinylated anti-TGF-b1 (LAP, 27240) were purchased from R&D Systems. PE-conjugated anti-IL-10 (JES3-19F1) and biotinylated anti-TGF-b (4492) (R&D Systems, Minneapolis, MN, USA) were used for intracellular cytokine staining.
The cell acquisition was performed on a FACSort flow cytometer using and CellQuest software (BD Biosciences). Unconjugated anti-CD3 (UCHT 1) and anti-CD28 (CD28.2) (BD Biosciences) were used for polyclonal activation.
PBMC and lesion mononuclear cell isolation Peripheral blood mononuclear cells from AC patients and health controls subjects were obtained by centrifuging whole blood through a Ficoll-Hypaque gradient (SigmaAldrich). The AC biopsies were collected from the lesions using a 4-mm biopsy punch, and digested in serum-free RPMI medium with 500 lg/ml liberase CI (Roche, Basel, Switzerland) for 1 h at 37°C. They were then macerated in medcons (BD Biosciences). The cell suspension was centrifuged through a Ficoll-Hypaque gradient (SigmaAldrich), and the mononuclear cells were isolated and quantified. The leukocytes viability was evaluated by Trypan blue exclusion.
CD4
+ CD25 high T-cell separation and cultures CD4 + CD25 high T cells were enriched using a CD4
Treg isolation kit (Miltenyi Biotec), according to manufacturer's instructions. CD4 + CD25 + T cells were isolated from PBMCs and AC lesions by a first step of negative sorting using a cocktail of hapten-conjugated CD8, CD11b, CD16, CD19, CD36, and CD56 antibodies and microbeads coupled to an antihapten monoclonal antibody (CD4 + T-cell isolation kit; Miltenyi Biotec, Bergisch Gladbach, Germany). This was followed by a step of positive selection of CD25 + cells by microbead separation (CD25 microbeads; Miltenyi Biotech), a procedure yielding to 90% or more purity as assessed by flow cytometric counting of CD4 + CD25 + cells.
Immunosuppression assay
In order to verify the suppressor activity of Tregs, CD4 + CD25 + T cells (1 9 10 5 cells/well) were first activated as previously described (18, 19) . For Immunosuppression assay, the total PBMC from autologus individuals were stained with CFSE and cultured alone or in presence of CD4 + CD25 + T cells (1 9 10 4 cells/well) with or without 1 lg/ml PHA (18).
T cell proliferation
Cells were cultured for 96 h at 37 C in a 5% CO 2 atmosphere, and CFSE + cells were analyzed regarding staining dilution (proliferative response). For each sample, CFSE dilution was evaluated in PHA-stimulated cultures, in the presence or absence of different amounts of purified CD4 + CD25 + cells. T-cells proliferation was characterized by sequential halving of CFSE fluorescence, generating equally spaced peaks on a logarithmic scale (19) . Data represent the percentage of inhibition calculated on the PHA-induced proliferation of allogeneic T cells cultured with PHA in the absence of CD4
Detection of cytokine by ELISA Actinic cheilitis samples were thawed on ice and homegeneized in a solution containing 2 mg of protease inhibitor (Boehringer I Mannheim, Indianapolis, IN, USA). Organ extracts were centrifuged to remove all particulate material. IL-10, TGF-b, and IFN-c levels were measured using ELISA kits (BD or R&D Systems), according to the manufacturer's instructions. The cytokine levels in skin homogenates were normalized to the protein levels measured using a Bradford assay. IL-10, TGF-b, and IFN-c levels also were quantified in the supernatants immunosuppression assay.
Statistical analysis
Data obtained from flow cytometry and cells proliferation assay were expressed as the standard error of the mean (SEM). Statistical analysis was performed using one way ANOVA followed by the Tukey's multiple comparison test (PRISM Software; GraphPad, La Jolla, CA, USA). P values ≤0.05 were considered statistically significant.
Results
Phenotypic and functional characterization of Treg cells in PBMC from AC patients First, we analyzed lymphocytes profiles in PBMC samples from AC patients and healthy controls subjects (Fig. 1 (Fig. 1B) . Furthermore, we found no significant differences in suppression activity of CD4 + CD25 + T cells from patients and controls (Fig. 1B) . However, only CD4 + CD25
+ cells from AC patients inhibited PHA-stimulated IFN-c secretion and induced increased levels of IL-10 ( Fig. 1C) .
CD4
+ CD25 + T cells isolated from AC lesions present regulatory profile and exert suppressive activity Histological analysis revealed that AC lesions presented hyperkeratosis, epithelial atrophy and acanthosis, vasodilatation, and elastosis ( Fig. 2A) . In the dermis was observed the presence of inflammatory infiltrate of intensity varying. To determine the lymphocytes profiles in AC lesions, isolation of leukocytes and flow cytometric experiments was performed. As shown in the insert in Fig. 2B , a great number of leukocytes (4.8 AE 0. Fig. 2A) .
In addition, lower levels of IFN-c and higher levels of IL-10 and TGF-b into AC lesions were observed as compared to healthy gingival tissue (Fig. 2C) . To verify the suppressor activity of AC lesion-derived CD4 + CD25 + T cells, proliferative experiments were performed. CD4 + CD25
+ T cells isolated from AC samples inhibited the allogeneic T-cells proliferation induced by PHA (SI = 29.8 AE 2.8%) (Fig. 2D) . These results confirmed that functional Treg cells accumulate in AC lesions.
Discussion
Regulatory T cells are known to control the intensity of efficient responses through a large number of mechanisms, including the production of TGF-b, CTLA-4 expression on their cell membrane, and intracellular Foxp3 (11, (20) (21) (22) (23) (24) (25) (26) . Growing evidences show that Tregs dampen T-cell immunity to tumor-associated antigens being one of the most important barrier damaging successful immune response and active vaccination (11, 25, 26) .
In spite of studies concerning Tregs and cancer, there are limited data relating these cells and potentially malignant lesion. As we have previously demonstrated that Tregs are abundant in OSCC lesions (11, 27) and AC is described as a lesion with potential to develop in OSCC (2), we decided to evaluate the presence and function of these cells in blood and lesions from AC patients. We hypothesize that Treg cells in a malignant environment impairs T-cells-mediated immune response, thereby leaving the development of SCC. Because Tregs on AC lesion are originated from systemic circulation, first, we analyzed the phenotypic difference of circulating CD4 + CD25 + T cells from AC individuals and controls subjects. Although our data demonstrated that Tregs existed at the same frequency in both groups, the frequencies of IL-10-positive Tregs were higher in AC patients. This variability observed in the groups could be indicating a direct association between high frequencies of circulating IL-10-positive Treg cells which a presence of the antiinflammatory response in AC patients (28) . For example, in diseases with an IL-10 over-production, undesired immunosuppressive effects of IL-10 and the growth of some tumors can be observed (28) .
It is possible that circulating IL-10-positive Tregs migrate to the potentially malignant lesion where they impair anticancer Th1 immunity. In fact, our results show that CD4 + CD25 + T cells were present in AC lesions and around 80% of them were Foxp3 + . Tregs may be subdivided based on Foxp3 expression and cytokine profile (29) . The main task of Foxp3 + Treg cells is to migrate to inflammation sites and suppress various effector lymphocytes, especially helper T (Th) cell subsets: Th1, Th2, Th17, and follicular Th (Tfh) cells (30) . Besides, Tregs have a core module of suppression driven by Foxp3 expression, where they are also able to adapt to changes in their environment and harness additional modules by the expression of other transcription factors normally associated with other T cell subtypes in order to better control immunopathology (30) . + T cells expressed IL-10. Although many cell types might be producing them (26, 27) , our results indicated that the Tregs might be the major source of IL-10 in AC microenvironment. IL-10-producing cells have been suggested to contribute to an immune suppressive tumor microenvironment (31, 32) . It is possible to speculate that circulating IL-10 + Tregs migrate to the potentially malignant lesion and impair anticancer Th1 immunity. In fact, recently, it has been shown that tumorassociated IL-10 was produced by an activated Treg population (31) . IL-10 + Tregs in the tumor required type I IFN signaling pathway and that, together, IL-10 and type I IFN act in a network that is required to limit Th17-type inflammation specifically in tumor microenvironment (31, 33) . Although in this study, we not have focused on the role of Th17 cells on antitumor response, others have observed that Th17 cells and Th17-associated cytokines have been shown to have both antitumorigenic and pro-tumorigenic functions (34) . Tregs and Th17 cells shared immunosuppressive mechanisms and have their function associated to TGF-b production (34) . TGF-b contributes to the inhibition of anticancer immunity (15) . During tumor progression, excess TGF-b suppresses immune surveillance by attenuating the antitumor functions of CD8 + T cells, CD4 + T cells, and dendritic cells (35) . In this way, the presence of TGF + Tregs could be impair anticancer Th1 immunity (19, 21, (35) (36) (37) . The expression of Tregs-associated markers IL-10, TGF-b, Foxp3, and CTLA-4, as well as the influx of Tregs into the AC microenvironment could determine a worse prognosis to the host, as observed in others types of tumor (38, 39) .
Actinic cheilitis lesions consists in morphologically altered tissue in which external factor is responsible for the etiology and malignant transformation; it carries the risk of oral OSCC (40) . From this point, the presence of Foxp3 + Tregs accumulated in AC lesions would be able to inhibit Tcell proliferation in situ, generating a microenvironment poor in cytokines with known antitumor activity, high levels of suppressor cytokines (IL-10 and TGF-b) (20, 26, 27, 29, 30, (36) (37) (38) (39) 41) . In fact, our data demonstrated low levels of IFN-c in AC lesions. Evidence has suggested a critical role of IFN-c on tumor immunity, and this cytokine plays a role important in the antitumor effector mechanisms (42) (43) (44) . Blockage of IFN-c has been shown to inhibit the tumor regression as it plays two distinct roles in expressing the antitumor efficacy of IL-12: one is to support the T-cell acceptability of tumor masses, and the other is to mediate the antitumor effects of migrated T cells (43, 45) . Thus, as the effective T cell antitumor response depends on the IFNc, its low levels detected in the lesions might facilitate the AC persistence, recurrence, progression, or malignization.
The specific inhibitor/regulatory role of CD25 + Foxp3 + T cells in AC lesions had not been previously investigated. We observed that AC microenvironment exhibited infiltration of Tregs cells presenting phenotype and function consistent with natural Tregs (45) . Treg-mediated immunosuppression may characterize one of the immune evasion mechanisms facilitating the relapse of this disease or even its malignization to OSCC (2, 46, 47) . According to our results, the presence of Tregs in AC lesions may be, in part, responsible for downregulation of immune responses impairs T-cell proliferation and cytokines production. As AC is a potentially malignant lesion, the presence of Treg cells could be one important factor addressing the tumor onset (2, 47) . Further studies are necessary to establish exact influence of Tregs on activated T cells and their role in the regulation of AC lesion. Understanding the role of Tregs infiltrating AC lesion might contribute with novel therapeutic interventions. The presence of these cells might be responsible for impaired cellular immunity against this potentially malignant lesion and, consequently, be involved in its malignant transformation.
